United Kingdom

Takara Bio Inc (4974.T)

4974.T on Tokyo Stock Exchange

24 Nov 2017
Change (% chg)

¥26 (+1.77%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Select another date:

Wed, Sep 27 2017

BRIEF-Takara Bio say first patient enrolled into phase I clinical trial of Oncolytic Virus HF10 in Japan

* Says the first patient with pancreatic cancer has been enrolled into Oncolytic Virus HF10(TBI-1401) phase I clinical trial in Japan on Sept. 26

BRIEF-Takara Bio starts first test of Phase II clinical trial of HF10

* Says it started first test of Phase II clinical trial of HF10, which will be used for treatment in patients with unresectable or metastatic melanoma, on May 26

Select another date: